The Enterprise Value as of December 2025 (TTM) for ArriVent BioPharma, Inc. Common Stock (AVBP) is 892.49M

According to ArriVent BioPharma, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 892.49M. This represents a change of 39.80% compared to the average of 638.38M of the last 4 quarters.

ArriVent BioPharma, Inc. Common Stock (AVBP) Historical Enterprise Value (quarterly & annually)

How has AVBP Enterprise Value performed in the past?

The mean historical Enterprise Value of ArriVent BioPharma, Inc. Common Stock over the last ten years is 437.04M. The current 892.49M Enterprise Value has changed 20.32% with respect to the historical average. Over the past ten years (40 quarters), AVBP's Enterprise Value was at its highest in in the March 2023 quarter at 833.25M. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.

ArriVent BioPharma, Inc. Common Stock (AVBP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ArriVent BioPharma, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ArriVent BioPharma, Inc. Common Stock (AVBP) Average Enterprise Value

How has AVBP Enterprise Value performed in the past?

The current Enterprise Value of ArriVent BioPharma, Inc. Common Stock (AVBP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ArriVent BioPharma, Inc. Common Stock (AVBP) Enterprise Value vs. Peers

How is AVBP’s Enterprise Value compared to its peers?

ArriVent BioPharma, Inc. Common Stock’s Enterprise Value is greater than MeiraGTx Holdings plc (679.86M), greater than Replimune Group, Inc. (804.93M), greater than Astria Therapeutics, Inc. (677.40M), greater than MBX Biosciences, Inc. Common Stock (803.43M), greater than Ginkgo Bioworks Holdings, Inc. (815.10M), greater than Iovance Biotherapeutics, Inc. (650.41M), greater than Valneva SE (687.21M), greater than Erasca, Inc. (888.32M), greater than Arvinas, Inc. (819.49M), greater than Day One Biopharmaceuticals, Inc. (815.93M),

Build a custom stock screener for ArriVent BioPharma, Inc. Common Stock (AVBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ArriVent BioPharma, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ArriVent BioPharma, Inc. Common Stock (AVBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ArriVent BioPharma, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.